Attached files
file | filename |
---|---|
S-1/A - Targeted Medical Pharma, Inc. | v219169_s1a.htm |
EX-14 - Targeted Medical Pharma, Inc. | v219169_ex14.htm |
EX-21 - Targeted Medical Pharma, Inc. | v219169_ex21.htm |
EX-4.1 - Targeted Medical Pharma, Inc. | v219169_ex4-1.htm |
EX-5.1 - Targeted Medical Pharma, Inc. | v219169_ex5-1.htm |
EX-99.3 - Targeted Medical Pharma, Inc. | v219169_ex99-3.htm |
EX-99.2 - Targeted Medical Pharma, Inc. | v219169_ex99-2.htm |
EX-99.1 - Targeted Medical Pharma, Inc. | v219169_ex99-1.htm |
EX-10.30 - Targeted Medical Pharma, Inc. | v219169_ex10-30.htm |
EX-10.28 - Targeted Medical Pharma, Inc. | v219169_ex10-28.htm |
EX-10.29 - Targeted Medical Pharma, Inc. | v219169_ex10-29.htm |
EX-10.21 - Targeted Medical Pharma, Inc. | v219169_ex10-21.htm |
EX-10.31 - Targeted Medical Pharma, Inc. | v219169_ex10-31.htm |
Exhibit 23.1
Certified Public Accountants | 280 Kenneth Drive, Suite 100 | Rochester, New York 14623 | 585.427.8900 | EFPRotenberg.com
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Targeted Medical Pharma, Inc.
2980 Beverly Glen Circle
Suite 301
Los Angeles, California
We hereby consent to the use in the Registration Statement on Form S-1 of our report dated April 14, 2011, relating to the financial statements of Targeted Medical Pharma, Inc. which is contained in that Registration Statement. We also consent to the reference to us under the caption, “Experts”, in this Registration Statement.
EFP Rotenberg, LLP
Rochester, New York
April 22, 2011